A shot twice a year to prevent the approval of HIV in us

The United States agreed to the world’s shot only twice a year to prevent HIV, according to its maker Gilead Sciences on Wednesday.

It is the first step in an expected global start starting that can protect millions – although it is not clear number in the United States and abroad, will be able to reach the strong new option.

Although the vaccine to prevent HIV is still required, some experts say this medicine – a drug called LenacAPAVIR – can be the best thing next. It has eliminated almost new infections in two pioneering studies of people at great risk, better than the daily preventive grains that they can forget to take.

“This really has the possibility of ending HIV.”

The condom helps protect from HIV infection if used properly, but something called preparatory – regularly using preventive drugs, such as daily grains or a different shot every two months – more important.

The six-month-long Lenacapavir protection makes it the longest-type-option can attract cautious people from doctor’s visits or the most common shame from daily birth control pills.

But US health care disturbances – including cuts in public health and doctor agencies – and reduce American foreign aid to fight HIV are expecting expectations.

Millite said that “the huge holes in the system” in the United States and at the global level “will make it difficult for us to make sure that we not only enter Lenacapavir into the bodies of people, but also make sure they return,” even less than twice a year.

GileAd has already been sold for HIV treatment under the name of the Sunlenca brand, which was inserted as approved in the health Canada database. The prevention dose will be sold under a different name, yeztuo. It is given as two injections under the skin of the abdomen, leaving a small “warehouse” of medications to absorb it slowly in the body.

Gilead has not immediately announced its price. The drug only prevents the transmission of HIV. It does not prevent other sexually transmitted diseases.

Global efforts have stopped ending HIV by 2030. There are still more than 30,000 new infections in the United States every year and about 1.3 million worldwide.

Only about 400,000 Americans are already using a form of preparatory forms, which is a small part of estimates to benefit. A recent study found that the countries that have a great use have witnessed a decrease in HIV infections, while rates continued to rise elsewhere.

The participant says that he forgets that he is in preparatory

About half of the new infections in women, who often need protection that they can use without the partner’s knowledge or approval.

One of the strict study in South Africa and Uganda compared more than 5,300 young women sexually stimulants and teenage girls that are prohibited twice Lenaciapavir or daily birth control pills. There was no HIV infection in those who receive the snapshot, while about two percent in the comparison group caught HIV from the injured sex partners.

A second study found that the snapshot twice in the annual is almost effective in gay men and people who are not gender in the United States and in many other countries damaged by HIV.

Ian Haddouk, who has lived in Houston, has tried the preparation since 2015. But he jumped to the opportunity to participate in the study of LenacAPAVIR and continues with the shots twice two years as part of following the research.

Haddock, who leads the regular anomalies initiative, said non -profit societies that serve Black 2LGBTQ+ regular anomalies, which are non -profit societies that serve Black 2LGBTQ+ unimaginable societies that serve Black 2LGBTQ+ Black 2LGBTQ+: “Now I now forget that I am in preparatory preparation because I do not have to have to Carry a pill bottle. “

“Men, women, gay, straight – it is really just a kind of expansion of the opportunity to prevent,” he said.

Haddock added that just remembering a visit clinic every six months “is a powerful tool in exchange for constantly having to talk about it, such as a condom, and constantly making sure to take birth control pills every day.”

“Every person in every country is at risk of HIV infection needs preparatory,” said Dr. Gordon Croffout, who helped lead the study in men. “We need to get easy access to preparatory that is very effective, like this.”

---

The Ministry of Health and Science at Associated Press receives support from the Science Education Department at the Howard Hughes Institute for the Medical Institute and the Robert Wood Johnson Foundation. AP is the only responsible for all content.